Investigating how anti-malarial treatments during pregnancy and childhood affect growth in children
Evaluating the causal effects of anti-malarial chemoprevention in pregnancy and childhood on growth outcomes
This study is looking at how giving anti-malarial treatments to pregnant women and young children can help reduce malaria and improve the growth of kids under five in sub-Saharan Africa.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11081619 on NIH RePORTER |
What this research studies
This research focuses on understanding the impact of anti-malarial chemoprevention on the growth outcomes of children under five years old in sub-Saharan Africa. It aims to evaluate how intermittent preventive treatments given to pregnant women and young children can reduce malaria infections and improve growth metrics. By analyzing the relationship between malaria, inflammation, and gut health, the study seeks to identify effective interventions that could enhance child health and development. The methodology includes systematic assessments of growth outcomes in relation to these treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women and children under the age of five living in high malaria transmission areas.
Not a fit: Patients who are not pregnant or do not have children under five years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved growth and health outcomes for children at risk of malaria in sub-Saharan Africa.
How similar studies have performed: Previous research has shown that anti-malarial treatments can effectively reduce malaria infections, but this study aims to explore their specific impact on child growth outcomes, making it a novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Nguyen, Anna Thuy Nhu — Stanford University
- Study coordinator: Nguyen, Anna Thuy Nhu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.